China · Delayed Price · Currency is CNY Lifecome Biochemistry Statistics
Total Valuation
SHE:002868 has a market cap or net worth of CNY 5.92 billion. The enterprise value is 6.37 billion.
| Market Cap | 5.92B |
| Enterprise Value | 6.37B |
Important Dates
The last earnings date was Tuesday, March 10, 2026.
| Earnings Date | Mar 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:002868 has 155.42 million shares outstanding. The number of shares has decreased by -0.52% in one year.
| Current Share Class | 155.42M |
| Shares Outstanding | 155.42M |
| Shares Change (YoY) | -0.52% |
| Shares Change (QoQ) | -4.86% |
| Owned by Insiders (%) | 24.13% |
| Owned by Institutions (%) | 5.04% |
| Float | 88.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.45 |
| PB Ratio | 91.12 |
| P/TBV Ratio | 140.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -45.74 |
| EV / Sales | 12.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -41.13 |
Financial Position
The company has a current ratio of 0.35, with a Debt / Equity ratio of 7.82.
| Current Ratio | 0.35 |
| Quick Ratio | 0.18 |
| Debt / Equity | 7.82 |
| Debt / EBITDA | 35.37 |
| Debt / FCF | -3.28 |
| Interest Coverage | -1.55 |
Financial Efficiency
Return on equity (ROE) is -689.73% and return on invested capital (ROIC) is -11.16%.
| Return on Equity (ROE) | -689.73% |
| Return on Assets (ROA) | -4.66% |
| Return on Invested Capital (ROIC) | -11.16% |
| Return on Capital Employed (ROCE) | -55.12% |
| Weighted Average Cost of Capital (WACC) | 9.80% |
| Revenue Per Employee | 940,947 |
| Profits Per Employee | -253,669 |
| Employee Count | 549 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 5.24 |
Taxes
In the past 12 months, SHE:002868 has paid 453,794 in taxes.
| Income Tax | 453,794 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +142.14% in the last 52 weeks. The beta is 1.03, so SHE:002868's price volatility has been similar to the market average.
| Beta (5Y) | 1.03 |
| 52-Week Price Change | +142.14% |
| 50-Day Moving Average | 38.17 |
| 200-Day Moving Average | 31.54 |
| Relative Strength Index (RSI) | 44.18 |
| Average Volume (20 Days) | 1,408,115 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002868 had revenue of CNY 516.58 million and -139.26 million in losses. Loss per share was -0.90.
| Revenue | 516.58M |
| Gross Profit | 15.89M |
| Operating Income | -83.50M |
| Pretax Income | -138.85M |
| Net Income | -139.26M |
| EBITDA | 11.34M |
| EBIT | -83.50M |
| Loss Per Share | -0.90 |
Balance Sheet
The company has 55.60 million in cash and 507.55 million in debt, with a net cash position of -451.94 million or -2.91 per share.
| Cash & Cash Equivalents | 55.60M |
| Total Debt | 507.55M |
| Net Cash | -451.94M |
| Net Cash Per Share | -2.91 |
| Equity (Book Value) | 64.93M |
| Book Value Per Share | 0.41 |
| Working Capital | -389.55M |
Cash Flow
In the last 12 months, operating cash flow was -25.08 million and capital expenditures -129.80 million, giving a free cash flow of -154.88 million.
| Operating Cash Flow | -25.08M |
| Capital Expenditures | -129.80M |
| Depreciation & Amortization | 94.84M |
| Net Borrowing | 240.32M |
| Free Cash Flow | -154.88M |
| FCF Per Share | -1.00 |
Margins
Gross margin is 3.08%, with operating and profit margins of -16.16% and -26.96%.
| Gross Margin | 3.08% |
| Operating Margin | -16.16% |
| Pretax Margin | -26.88% |
| Profit Margin | -26.96% |
| EBITDA Margin | 2.20% |
| EBIT Margin | -16.16% |
| FCF Margin | n/a |
Dividends & Yields
SHE:002868 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.52% |
| Shareholder Yield | 0.52% |
| Earnings Yield | -2.35% |
| FCF Yield | -2.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2020. It was a forward split with a ratio of 1.3.
| Last Split Date | May 28, 2020 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHE:002868 has an Altman Z-Score of 1.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.78 |
| Piotroski F-Score | 5 |